Combining radionuclide therapy with a PARP inhibitor slows neuroendocrine tumor growth
Credit: S. Adant, J.M. Beauregard, N.K. Purohit, R.G. Shah, and G.M. Shah, Université Laval, Quebec City, Canada DENVER, Colo. - Cancer of the neuroendocrine system...





